These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22530707)

  • 1. Chitosan: a potential polymer for colon-specific drug delivery system.
    Gulbake A; Jain SK
    Expert Opin Drug Deliv; 2012 Jun; 9(6):713-29. PubMed ID: 22530707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan and its role in ocular therapeutics.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Mini Rev Med Chem; 2009 Dec; 9(14):1639-47. PubMed ID: 20105127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery.
    Maestrelli F; Cirri M; Mennini N; Bragagni M; Zerrouk N; Mura P
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1142-51. PubMed ID: 22191551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
    Kumar J; Newton AMJ
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan: a propitious biopolymer for drug delivery.
    Duttagupta DS; Jadhav VM; Kadam VJ
    Curr Drug Deliv; 2015; 12(4):369-81. PubMed ID: 25761010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
    Pahwa R; Saini N; Kumar V; Kohli K
    Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
    George M; Abraham TE
    J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
    Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
    Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone.
    Gadalla HH; Soliman GM; Mohammed FA; El-Sayed AM
    Drug Deliv; 2016 Sep; 23(7):2541-2554. PubMed ID: 25853478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin.
    Bigucci F; Luppi B; Cerchiara T; Sorrenti M; Bettinetti G; Rodriguez L; Zecchi V
    Eur J Pharm Sci; 2008 Dec; 35(5):435-41. PubMed ID: 18951977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
    Newton AM; Indana VL; Kumar J
    Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
    Islam N; Ferro V
    Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan and its derivatives as intestinal absorption enhancers.
    Thanou M; Verhoef JC; Junginger HE
    Adv Drug Deliv Rev; 2001 Oct; 50 Suppl 1():S91-101. PubMed ID: 11576697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular application of chitosan.
    Başaran E; Yazan Y
    Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
    Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
    Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.